Puzo Michael J Increases Stake in UnitedHealth Group Incorporated $UNH

Puzo Michael J lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,653 shares of the healthcare conglomerate’s stock after purchasing an additional 670 shares during the quarter. UnitedHealth Group comprises about 1.5% of Puzo Michael J’s portfolio, making the stock its 28th largest holding. Puzo Michael J’s holdings in UnitedHealth Group were worth $5,195,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Citizens National Bank Trust Department raised its position in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after purchasing an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH raised its position in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares during the last quarter. Caitlin John LLC raised its position in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares during the last quarter. Triumph Capital Management purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $1,324,000. Finally, Wealth Effects LLC raised its position in UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after buying an additional 591 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $363.95 on Wednesday. The company’s fifty day moving average price is $311.44 and its 200 day moving average price is $352.42. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market capitalization of $329.62 billion, a P/E ratio of 15.77, a P/E/G ratio of 2.33 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Barclays raised their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, Oppenheimer dropped their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $365.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.